Primary tumor dependent inhibition of tumor growth, angiogenesis, and perfusion of secondary breast cancer in bone

Journal of Orthopaedic Research

Volumn 29, Issue 8, 2011, Pages 1251-1258

  Schaefer, Christian ^a   Schroeder, Malte ^a   Fuhrhop, Ina ^a   Viezens, Lennart ^a   Otten, Jasmin ^a   Fiedler, Walter ^a   Rüther, Wolfgang ^a   Hansen Algenstaedt, Nils ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

angiogenesis; bone; intravital microscopy; microcirculation; surgery; tumor

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD FLOW VELOCITY; BLOOD VESSEL DIAMETER; BLOOD VESSEL PERMEABILITY; BONE METASTASIS; BREAST CANCER; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; MASTECTOMY; MICROVASCULATURE; MOUSE; NONHUMAN; PRIMARY TUMOR; PRIORITY JOURNAL; TISSUE PERFUSION; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BLOOD FLOW VELOCITY; BONE NEOPLASMS; BREAST NEOPLASMS; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; FEMALE; FEMUR; HUMANS; MICE; MICE, SCID; NEOPLASTIC PROCESSES; NEOVASCULARIZATION, PATHOLOGIC;

EID: 79958865990     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.21402     Document Type: Article

References (36)

1. Rofstad EK, Graff BA,. 2001. Thrombospondin-1-mediated metastasis suppression by the primary tumor in human melanoma xenografts. J Invest Dermatol 117: 1042-1049. (Pubitemid 34205896)
2. Kaya M, Wada T, Nagoya S, et al. 2007. Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin. J Orthop Sci 12: 562-567. (Pubitemid 350190510)
3. Scharovsky OG, Binda MM, Rozados VR, et al. 2004. Angiogenic and antiangiogenic balance regulates concomitant antitumoral resistance. Clin Exp Metastasis 21: 177-183. (Pubitemid 38988091)
4. Tsunemi T, Nagoya S, Kaya M, et al. 2003. Postoperative progression of pulmonary metastasis in osteosarcoma. Clin Orthop 407: 159-166. (Pubitemid 36176505)
5. Guba M, Cernaianu G, Koehl G, et al. 2001. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res 61: 5575-5579. (Pubitemid 32694945)
6. Gohongi T, Fukumura D, Boucher Y, et al. 1999. Tumor-host interactions in the gallbladder suppress distal angiogenesis and tumor growth: involvement of transforming growth factor beta1. Nat Med 5: 1203-1208. (Pubitemid 29474428)
7. Holmgren L, O'Reilly MS, Folkman J,. 1995. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1: 149-153.
8. Peeters CF, de Waal RM, Wobbes T, et al. 2006. Outgrowth of human liver metastases after resection of the primary colorectal tumor: a shift in the balance between apoptosis and proliferation. Int J Cancer 119: 1249-1253. (Pubitemid 44258796)
9. Peeters CF, Westphal JR, de Waal RM, et al. 2004. Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients. Int J Cancer 112: 554-559. (Pubitemid 39425934)
10. Ramanujan S, Koenig GC, Padera TP, et al. 2000. Local imbalance of proangiogenic and antiangiogenic factors: a potential mechanism of focal necrosis and dormancy in tumors. Cancer Res 60: 1442-1448. (Pubitemid 30152019)
11. Fukumura D, Yuan F, Monsky WL, et al. 1997. Effect of host microenvironment on the microcirculation of human colon adenocarcinoma. Am J Pathol 151: 679-688. (Pubitemid 27385599)
12. Hobbs SK, Monsky WL, Yuan F, et al. 1998. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95: 4607-4612. (Pubitemid 28207960)
13. Keyes KA, Mann L, Teicher B, et al. 2003. Site-dependent angiogenic cytokine production in human tumor xenografts. Cytokine 21: 98-104. (Pubitemid 36369396)
14. Fidler IJ,. 2002. The organ microenvironment and cancer metastasis. Differentiation 70: 498-505. (Pubitemid 36194315)
15. Ladeda V, Adam AP, Puricelli L, et al. 2001. Apoptotic cell death in mammary adenocarcinoma cells is prevented by soluble factors present in the target organ of metastasis. Breast Cancer Res Treat 69: 39-51. (Pubitemid 33079028)
16. Gu B, Espana L, Mendez O, et al. 2004. Organ-selective chemoresistance in metastasis from human breast cancer cells: inhibition of apoptosis, genetic variability and microenvironment at the metastatic focus. Carcinogenesis 25: 2293-2301. (Pubitemid 39625168)
17. Fuhrhop I, Schroeder M, Rafnsdottir SL, et al. 2010. Dynamics of microvascular remodelling during tumor growth in bone. J Orthop Res 28: 27-31.
18. Hansen-Algenstaedt N, Schaefer C, Wolfram L, et al. 2005. Femur window-a new approach to microcirculation of living bone in situ. J Orthop Res 23: 1073-1082. (Pubitemid 41245431)
19. Schaefer C, Fuhrhop I, Schroeder M, et al. 2010. Microcirculation of secondary bone tumors in vivo: the impact of minor surgery at a distal site. J Orthop Res 28: 1515-1521.
20. Lacroix M, Leclercq G,. 2004. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 83: 249-289. (Pubitemid 38264873)
21. Keydar I, Chen L, Karby S, et al. 1979. Establishment and characterization of a cell line of human breast carcinoma origin. Eur J Cancer 15: 659-670. (Pubitemid 9198534)
22. O'Reilly MS, Boehm T, Shing Y, et al. 1997. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88: 277-285. (Pubitemid 28015876)
23. Lipowsky HH, Zweifach BW,. 1978. Application of the "two-slit" photometric technique to the measurement of microvascular volumetric flow rates. Microvasc Res 15: 93-101. (Pubitemid 8303534)
24. Hansen-Algenstaedt N, Joscheck C, Schaefer C, et al. 2005. Long-term observation reveals time course dependent characteristics of tumorvascularization. Eur J Cancer 41: 1073-1085. (Pubitemid 40602861)
25. Schaefer C, Krause M, Fuhrhop I, et al. 2008. Time-course-dependent microvascular alterations in a model of myeloid leukemia in vivo. Leukemia 22: 59-65.
26. Brizel DM, Klitzman B, Cook JM, et al. 1993. A comparison of tumor and normal tissue microvascular hematocrits and red cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys 25: 269-276. (Pubitemid 23048779)
27. Yuan F, Leunig M, Huang SK, et al. 1994. Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. Cancer Res 54: 3352-3356. (Pubitemid 24225946)
28. Rosol TJ, Tannehill-Gregg SH, LeRoy BE, et al. 2003. Animal models of bone metastasis. Cancer 97: 748-757. (Pubitemid 36125810)
29. Klenke FM, Merkle T, Fellenberg J, et al. 2005. A novel model for the investigation of orthotopically growing primary and secondary bone tumours using intravital microscopy. Lab Anim 39: 377-383. (Pubitemid 41565458)
30. Sckell A, Safabakhsh N, Dellian M, et al. 1998. Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice. Cancer Res 58: 5866-5869. (Pubitemid 29006430)
31. Less JR, Posner MC, Skalak TC, et al. 1997. Geometric resistance and microvascular network architecture of human colorectal carcinoma. Microcirculation 4: 25-33. (Pubitemid 127717664)
32. Padera TP, Stoll BR, Tooredman JB, et al. 2004. Pathology: cancer cells compress intratumour vessels. Nature 427: 695. (Pubitemid 38294577)
33. Hatakawa H, Funakoshi N, Onizuka M, et al. 2002. Blood flow does not correlate with the size of metastasis in our new intravital observation model of Lewis lung cancer. Microvasc Res 64: 32-337.
34. Hlatky L, Hahnfeldt P, Folkman J,. 2002. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. JNCI Cancer Spectrum 94: 883-893. (Pubitemid 34778087)
35. Peeters CF, de Waal RM, Wobbes T, et al. 2008. Metastatic dormancy imposed by the primary tumor: does it exist in humans? Ann Surg Oncol 15: 3308-3315.
36. O'Reilly MS, Holmgren L, Shing Y, et al. 1994. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79: 315-328. (Pubitemid 24324921)